,,buckeyes,,,,I am not on any ledge with this investment,,,I am however super frustrated as many shareholders,..no selling of my 6 digit share number or my 5 digit warrant number,,my point of view at the moment has certainly regressed from those exciting days prior to the BoM results where adding to the position was a no brainer!!!!!!,,ugghhh,,,,we are told now that we have something here,,but need more trial data to confirm,,,,,,hang onto your shares DM says as we spiral down the abyss in shareprice!!,,,,,its complicated,,,CKD data was so exciting earlier in the Aussi trial but that seems to be an halucination on DMs part,,,changes in patient condition was said to be noted within hours of taking 208,,but nope not the case!,,no surprise there that the market would puke us up!!!,,,,,the data around dimentia seems to be now "as Bubbles would say" water under the fridge.....and on and on,,,,,,,,,then we have the secrecy week after week and month after month....wrinkle after wrinkle,,,grey hair after grey hair,,,only to learn of more disappointment in this research!!!

It would seem one should be able to negotiate in the back ground and still carry on with the day to day of selling the news to media etc who matter,,,not some half hindged web media outlet,,,,,,we should be reading about apabetalone every other day imo,,,,,and where has the idea that 208 regulates inflamation gone??..we are said to increase in inflammation as we age,,it sure feels that way.....and achhhhh,,,,we will never do anything with the library of hundreds of molecules,,, as we cant handle the one we have in play,,so move it,,,,sell the gd thing or part of it or other,,,,we need the $$$,,,,,,then we have the so called 8 to 10 year lead in epigenetics which also seems to be getting clouded out there,,or at least getting more so,,the market just either dones not believe us ,,it dont care,,or thinks it is not an advantage to be that advanced if true!,,based on our progress it is very possible that an epigenetic compound from elsewhere will be first to market,,,,,not us,,,,,that may not be a bad thing,,,however,,,we need management with past successful experience around taking a drug through FDA protocol,,,,, the investing world is well aware of the inability of this company to create shareholder value,,,,,and thats my beef,,....so change it RVX...what is not to understand!!!!,,,,its business,,,just business,,,,..jmo